Transscleral cyclophotocoagulation (TSCPC) is a procedure used to treat glaucoma by reducing the production of aqueous humor (the fluid inside the eye), which helps lower intraocular pressure (IOP). During the procedure, a laser is applied to the ciliary body, the part of the eye that produces fluid, effectively reducing fluid production and controlling IOP.

TSCPC is typically used for patients with advanced glaucoma or those who have not responded well to other treatments, such as medications or trabeculectomy. This minimally invasive procedure can help preserve vision and prevent further optic nerve damage caused by high IOP, with fewer complications and a faster recovery than traditional surgery.

Transscleral cyclophotocoagulation provides an effective solution for managing glaucoma, especially in patients with difficult-to-treat cases.